Index by author

April 01 1998; volume 47 issue 4

A

  1. Aganna, E

    1. Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians.
      G A Hitman, N Mannan, M F McDermott, E Aganna, B W Ogunkolade, C N Hales and B J Boucher
      Diabetes 1998 Apr; 47 (4): 688-690. https://doi.org/10.2337/diabetes.47.4.688

  2. Aguilar-Bryan, L

    1. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
      T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
      Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598

  3. Almind, K

    1. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
      T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
      Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598

  4. Andrikopoulos, S

    1. Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.
      S E Kahn, C B Verchere, S Andrikopoulos, P J Asberry, D L Leonetti, P W Wahl, E J Boyko, R S Schwartz, L Newell-Morris and W Y Fujimoto
      Diabetes 1998 Apr; 47 (4): 640-645. https://doi.org/10.2337/diabetes.47.4.640

  5. Araki, E

    1. Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
      K Tsuruzoe, E Araki, N Furukawa, T Shirotani, K Matsumoto, K Kaneko, H Motoshima, K Yoshizato, A Shirakami, H Kishikawa, J Miyazaki and M Shichiri
      Diabetes 1998 Apr; 47 (4): 621-631. https://doi.org/10.2337/diabetes.47.4.621

  6. Argyropoulos, G

    1. Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African-American subjects.
      G Argyropoulos, A M Brown, R Peterson, C E Likes, D K Watson and W T Garvey
      Diabetes 1998 Apr; 47 (4): 685-687. https://doi.org/10.2337/diabetes.47.4.685

  7. Asberry, P J

    1. Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.
      S E Kahn, C B Verchere, S Andrikopoulos, P J Asberry, D L Leonetti, P W Wahl, E J Boyko, R S Schwartz, L Newell-Morris and W Y Fujimoto
      Diabetes 1998 Apr; 47 (4): 640-645. https://doi.org/10.2337/diabetes.47.4.640

  8. Atkinson, M A

    1. The relationship between humoral and cellular immunity to IA-2 in IDDM.
      T M Ellis, D A Schatz, E W Ottendorfer, M S Lan, C Wasserfall, P J Salisbury, J X She, A L Notkins, N K Maclaren and M A Atkinson
      Diabetes 1998 Apr; 47 (4): 566-569. https://doi.org/10.2337/diabetes.47.4.566

B

  1. Babazono, T

    1. Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells.
      T Babazono, J Kapor-Drezgic, J A Dlugosz and C Whiteside
      Diabetes 1998 Apr; 47 (4): 668-676. https://doi.org/10.2337/diabetes.47.4.668

  2. Baldoncini, R

    1. Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.
      C Ferri, G Desideri, R Baldoncini, C Bellini, C De Angelis, C Mazzocchi and A Santucci
      Diabetes 1998 Apr; 47 (4): 660-667. https://doi.org/10.2337/diabetes.47.4.660

  3. Baskin, D G

    1. Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting.
      D G Baskin, R J Seeley, J L Kuijper, S Lok, D S Weigle, J C Erickson, R D Palmiter and M W Schwartz
      Diabetes 1998 Apr; 47 (4): 538-543. https://doi.org/10.2337/diabetes.47.4.538

  4. Beger, C

    1. Vascularization of purified pancreatic islet-like cell aggregates (pseudoislets) after syngeneic transplantation.
      C Beger, V Cirulli, P Vajkoczy, P A Halban and M D Menger
      Diabetes 1998 Apr; 47 (4): 559-565. https://doi.org/10.2337/diabetes.47.4.559

  5. Bellini, C

    1. Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.
      C Ferri, G Desideri, R Baldoncini, C Bellini, C De Angelis, C Mazzocchi and A Santucci
      Diabetes 1998 Apr; 47 (4): 660-667. https://doi.org/10.2337/diabetes.47.4.660

  6. Beshay, E

    1. The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice.
      L Liang, E Beshay and G J Prud'homme
      Diabetes 1998 Apr; 47 (4): 570-575. https://doi.org/10.2337/diabetes.47.4.570

  7. Boucher, B J

    1. Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians.
      G A Hitman, N Mannan, M F McDermott, E Aganna, B W Ogunkolade, C N Hales and B J Boucher
      Diabetes 1998 Apr; 47 (4): 688-690. https://doi.org/10.2337/diabetes.47.4.688

  8. Boyadjian, R

    1. Physiological insulinemia acutely modulates plasma leptin.
      M F Saad, A Khan, A Sharma, R Michael, M G Riad-Gabriel, R Boyadjian, S D Jinagouda, G M Steil and V Kamdar
      Diabetes 1998 Apr; 47 (4): 544-549. https://doi.org/10.2337/diabetes.47.4.544

  9. Boyko, E J

    1. Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.
      S E Kahn, C B Verchere, S Andrikopoulos, P J Asberry, D L Leonetti, P W Wahl, E J Boyko, R S Schwartz, L Newell-Morris and W Y Fujimoto
      Diabetes 1998 Apr; 47 (4): 640-645. https://doi.org/10.2337/diabetes.47.4.640

  10. Brown, A M

    1. Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African-American subjects.
      G Argyropoulos, A M Brown, R Peterson, C E Likes, D K Watson and W T Garvey
      Diabetes 1998 Apr; 47 (4): 685-687. https://doi.org/10.2337/diabetes.47.4.685

  11. Brubaker, P L

    1. Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling.
      L A Scrocchi, B A Marshall, S M Cook, P L Brubaker and D J Drucker
      Diabetes 1998 Apr; 47 (4): 632-639. https://doi.org/10.2337/diabetes.47.4.632

  12. Bryan, J

    1. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
      T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
      Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598

  13. Bursell, S E

    1. Reversibility of retinal flow abnormalities is disease-duration dependent in diabetic rats.
      S Higashi, A C Clermont, V Dhir and S E Bursell
      Diabetes 1998 Apr; 47 (4): 653-659. https://doi.org/10.2337/diabetes.47.4.653

C

  1. Castillo, G M

    1. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
      G M Castillo, J A Cummings, W Yang, M E Judge, M J Sheardown, K Rimvall, J B Hansen and A D Snow
      Diabetes 1998 Apr; 47 (4): 612-620. https://doi.org/10.2337/diabetes.47.4.612

  2. Cherrington, A D

    1. Basal hepatic glucose production is regulated by the portal vein insulin concentration.
      D K Sindelar, C A Chu, P Venson, E P Donahue, D W Neal and A D Cherrington
      Diabetes 1998 Apr; 47 (4): 523-529. https://doi.org/10.2337/diabetes.47.4.523

  3. Chu, C A

    1. Basal hepatic glucose production is regulated by the portal vein insulin concentration.
      D K Sindelar, C A Chu, P Venson, E P Donahue, D W Neal and A D Cherrington
      Diabetes 1998 Apr; 47 (4): 523-529. https://doi.org/10.2337/diabetes.47.4.523

  4. Cirulli, V

    1. Vascularization of purified pancreatic islet-like cell aggregates (pseudoislets) after syngeneic transplantation.
      C Beger, V Cirulli, P Vajkoczy, P A Halban and M D Menger
      Diabetes 1998 Apr; 47 (4): 559-565. https://doi.org/10.2337/diabetes.47.4.559

  5. Clausen, J O

    1. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
      T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
      Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598

  6. Clermont, A C

    1. Reversibility of retinal flow abnormalities is disease-duration dependent in diabetic rats.
      S Higashi, A C Clermont, V Dhir and S E Bursell
      Diabetes 1998 Apr; 47 (4): 653-659. https://doi.org/10.2337/diabetes.47.4.653

  7. Cook, S M

    1. Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling.
      L A Scrocchi, B A Marshall, S M Cook, P L Brubaker and D J Drucker
      Diabetes 1998 Apr; 47 (4): 632-639. https://doi.org/10.2337/diabetes.47.4.632

  8. Corbett, J A

    1. Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
      G Kwon, J A Corbett, S Hauser, J R Hill, J Turk and M L McDaniel
      Diabetes 1998 Apr; 47 (4): 583-591. https://doi.org/10.2337/diabetes.47.4.583

  9. Cummings, J A

    1. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
      G M Castillo, J A Cummings, W Yang, M E Judge, M J Sheardown, K Rimvall, J B Hansen and A D Snow
      Diabetes 1998 Apr; 47 (4): 612-620. https://doi.org/10.2337/diabetes.47.4.612

D

  1. De Angelis, C

    1. Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.
      C Ferri, G Desideri, R Baldoncini, C Bellini, C De Angelis, C Mazzocchi and A Santucci
      Diabetes 1998 Apr; 47 (4): 660-667. https://doi.org/10.2337/diabetes.47.4.660

  2. Desideri, G

    1. Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.
      C Ferri, G Desideri, R Baldoncini, C Bellini, C De Angelis, C Mazzocchi and A Santucci
      Diabetes 1998 Apr; 47 (4): 660-667. https://doi.org/10.2337/diabetes.47.4.660

  3. Dhir, V

    1. Reversibility of retinal flow abnormalities is disease-duration dependent in diabetic rats.
      S Higashi, A C Clermont, V Dhir and S E Bursell
      Diabetes 1998 Apr; 47 (4): 653-659. https://doi.org/10.2337/diabetes.47.4.653

  4. Dittler, J

    1. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
      J Dittler, D Seidel, M Schenker and A G Ziegler
      Diabetes 1998 Apr; 47 (4): 592-597. https://doi.org/10.2337/diabetes.47.4.592

  5. Dlugosz, J A

    1. Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells.
      T Babazono, J Kapor-Drezgic, J A Dlugosz and C Whiteside
      Diabetes 1998 Apr; 47 (4): 668-676. https://doi.org/10.2337/diabetes.47.4.668

  6. Donahue, E P

    1. Basal hepatic glucose production is regulated by the portal vein insulin concentration.
      D K Sindelar, C A Chu, P Venson, E P Donahue, D W Neal and A D Cherrington
      Diabetes 1998 Apr; 47 (4): 523-529. https://doi.org/10.2337/diabetes.47.4.523

  7. Drucker, D J

    1. Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling.
      L A Scrocchi, B A Marshall, S M Cook, P L Brubaker and D J Drucker
      Diabetes 1998 Apr; 47 (4): 632-639. https://doi.org/10.2337/diabetes.47.4.632
    2. Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
      D Flamez, A Van Breusegem, L A Scrocchi, E Quartier, D Pipeleers, D J Drucker and F Schuit
      Diabetes 1998 Apr; 47 (4): 646-652. https://doi.org/10.2337/diabetes.47.4.646

E

  1. Ebina, Y

    1. Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.
      K Kishi, N Muromoto, Y Nakaya, I Miyata, A Hagi, H Hayashi and Y Ebina
      Diabetes 1998 Apr; 47 (4): 550-558. https://doi.org/10.2337/diabetes.47.4.550

  2. Echwald, S M

    1. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
      T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
      Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598

  3. Eckel, J

    1. Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor.
      L S Liu, M Spelleken, K Röhrig, H Hauner and J Eckel
      Diabetes 1998 Apr; 47 (4): 515-522. https://doi.org/10.2337/diabetes.47.4.515

  4. Ellis, T M

    1. The relationship between humoral and cellular immunity to IA-2 in IDDM.
      T M Ellis, D A Schatz, E W Ottendorfer, M S Lan, C Wasserfall, P J Salisbury, J X She, A L Notkins, N K Maclaren and M A Atkinson
      Diabetes 1998 Apr; 47 (4): 566-569. https://doi.org/10.2337/diabetes.47.4.566

  5. Erickson, J C

    1. Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting.
      D G Baskin, R J Seeley, J L Kuijper, S Lok, D S Weigle, J C Erickson, R D Palmiter and M W Schwartz
      Diabetes 1998 Apr; 47 (4): 538-543. https://doi.org/10.2337/diabetes.47.4.538

  6. Eriksson, U J

    1. Antioxidants diminish developmental damage induced by high glucose and cyclooxygenase inhibitors in rat embryos in vitro.
      P Wentzel and U J Eriksson
      Diabetes 1998 Apr; 47 (4): 677-684. https://doi.org/10.2337/diabetes.47.4.677

F

  1. Ferrer, J

    1. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
      T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
      Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598

  2. Ferri, C

    1. Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.
      C Ferri, G Desideri, R Baldoncini, C Bellini, C De Angelis, C Mazzocchi and A Santucci
      Diabetes 1998 Apr; 47 (4): 660-667. https://doi.org/10.2337/diabetes.47.4.660

  3. Flamez, D

    1. Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
      D Flamez, A Van Breusegem, L A Scrocchi, E Quartier, D Pipeleers, D J Drucker and F Schuit
      Diabetes 1998 Apr; 47 (4): 646-652. https://doi.org/10.2337/diabetes.47.4.646

  4. Franciosa, M D

    1. BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones.
      S C Souza, M T Yamamoto, M D Franciosa, P Lien and A S Greenberg
      Diabetes 1998 Apr; 47 (4): 691-695. https://doi.org/10.2337/diabetes.47.4.691

  5. Fujimoto, W Y

    1. Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.
      S E Kahn, C B Verchere, S Andrikopoulos, P J Asberry, D L Leonetti, P W Wahl, E J Boyko, R S Schwartz, L Newell-Morris and W Y Fujimoto
      Diabetes 1998 Apr; 47 (4): 640-645. https://doi.org/10.2337/diabetes.47.4.640

  6. Furukawa, N

    1. Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
      K Tsuruzoe, E Araki, N Furukawa, T Shirotani, K Matsumoto, K Kaneko, H Motoshima, K Yoshizato, A Shirakami, H Kishikawa, J Miyazaki and M Shichiri
      Diabetes 1998 Apr; 47 (4): 621-631. https://doi.org/10.2337/diabetes.47.4.621

G

  1. Garvey, W T

    1. Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African-American subjects.
      G Argyropoulos, A M Brown, R Peterson, C E Likes, D K Watson and W T Garvey
      Diabetes 1998 Apr; 47 (4): 685-687. https://doi.org/10.2337/diabetes.47.4.685

  2. Greenberg, A S

    1. BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones.
      S C Souza, M T Yamamoto, M D Franciosa, P Lien and A S Greenberg
      Diabetes 1998 Apr; 47 (4): 691-695. https://doi.org/10.2337/diabetes.47.4.691

H

  1. Hagi, A

    1. Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.
      K Kishi, N Muromoto, Y Nakaya, I Miyata, A Hagi, H Hayashi and Y Ebina
      Diabetes 1998 Apr; 47 (4): 550-558. https://doi.org/10.2337/diabetes.47.4.550

  2. Halban, P A

    1. Vascularization of purified pancreatic islet-like cell aggregates (pseudoislets) after syngeneic transplantation.
      C Beger, V Cirulli, P Vajkoczy, P A Halban and M D Menger
      Diabetes 1998 Apr; 47 (4): 559-565. https://doi.org/10.2337/diabetes.47.4.559

  3. Hales, C N

    1. Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians.
      G A Hitman, N Mannan, M F McDermott, E Aganna, B W Ogunkolade, C N Hales and B J Boucher
      Diabetes 1998 Apr; 47 (4): 688-690. https://doi.org/10.2337/diabetes.47.4.688

  4. Hansen, J B

    1. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
      G M Castillo, J A Cummings, W Yang, M E Judge, M J Sheardown, K Rimvall, J B Hansen and A D Snow
      Diabetes 1998 Apr; 47 (4): 612-620. https://doi.org/10.2337/diabetes.47.4.612

  5. Hansen, L

    1. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
      T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
      Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598

  6. Hansen, T

    1. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
      T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
      Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598

  7. Hauner, H

    1. Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor.
      L S Liu, M Spelleken, K Röhrig, H Hauner and J Eckel
      Diabetes 1998 Apr; 47 (4): 515-522. https://doi.org/10.2337/diabetes.47.4.515

  8. Hauser, S

    1. Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
      G Kwon, J A Corbett, S Hauser, J R Hill, J Turk and M L McDaniel
      Diabetes 1998 Apr; 47 (4): 583-591. https://doi.org/10.2337/diabetes.47.4.583

  9. Hayashi, H

    1. Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.
      K Kishi, N Muromoto, Y Nakaya, I Miyata, A Hagi, H Hayashi and Y Ebina
      Diabetes 1998 Apr; 47 (4): 550-558. https://doi.org/10.2337/diabetes.47.4.550

  10. Higashi, S

    1. Reversibility of retinal flow abnormalities is disease-duration dependent in diabetic rats.
      S Higashi, A C Clermont, V Dhir and S E Bursell
      Diabetes 1998 Apr; 47 (4): 653-659. https://doi.org/10.2337/diabetes.47.4.653

  11. Hill, J R

    1. Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
      G Kwon, J A Corbett, S Hauser, J R Hill, J Turk and M L McDaniel
      Diabetes 1998 Apr; 47 (4): 583-591. https://doi.org/10.2337/diabetes.47.4.583

  12. Hitman, G A

    1. Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians.
      G A Hitman, N Mannan, M F McDermott, E Aganna, B W Ogunkolade, C N Hales and B J Boucher
      Diabetes 1998 Apr; 47 (4): 688-690. https://doi.org/10.2337/diabetes.47.4.688

I

  1. Inoue, H

    1. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
      T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
      Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598

J

  1. Jinagouda, S D

    1. Physiological insulinemia acutely modulates plasma leptin.
      M F Saad, A Khan, A Sharma, R Michael, M G Riad-Gabriel, R Boyadjian, S D Jinagouda, G M Steil and V Kamdar
      Diabetes 1998 Apr; 47 (4): 544-549. https://doi.org/10.2337/diabetes.47.4.544

  2. Judge, M E

    1. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
      G M Castillo, J A Cummings, W Yang, M E Judge, M J Sheardown, K Rimvall, J B Hansen and A D Snow
      Diabetes 1998 Apr; 47 (4): 612-620. https://doi.org/10.2337/diabetes.47.4.612

  3. Jun, H S

    1. Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein.
      H S Jun, Y Kang, H S Yoon, K H Kim, A L Notkins and J W Yoon
      Diabetes 1998 Apr; 47 (4): 576-582. https://doi.org/10.2337/diabetes.47.4.576

K

  1. Kahn, S E

    1. Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.
      S E Kahn, C B Verchere, S Andrikopoulos, P J Asberry, D L Leonetti, P W Wahl, E J Boyko, R S Schwartz, L Newell-Morris and W Y Fujimoto
      Diabetes 1998 Apr; 47 (4): 640-645. https://doi.org/10.2337/diabetes.47.4.640

  2. Kamdar, V

    1. Physiological insulinemia acutely modulates plasma leptin.
      M F Saad, A Khan, A Sharma, R Michael, M G Riad-Gabriel, R Boyadjian, S D Jinagouda, G M Steil and V Kamdar
      Diabetes 1998 Apr; 47 (4): 544-549. https://doi.org/10.2337/diabetes.47.4.544

  3. Kaneko, K

    1. Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
      K Tsuruzoe, E Araki, N Furukawa, T Shirotani, K Matsumoto, K Kaneko, H Motoshima, K Yoshizato, A Shirakami, H Kishikawa, J Miyazaki and M Shichiri
      Diabetes 1998 Apr; 47 (4): 621-631. https://doi.org/10.2337/diabetes.47.4.621

  4. Kang, Y

    1. Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein.
      H S Jun, Y Kang, H S Yoon, K H Kim, A L Notkins and J W Yoon
      Diabetes 1998 Apr; 47 (4): 576-582. https://doi.org/10.2337/diabetes.47.4.576

  5. Kapor-Drezgic, J

    1. Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells.
      T Babazono, J Kapor-Drezgic, J A Dlugosz and C Whiteside
      Diabetes 1998 Apr; 47 (4): 668-676. https://doi.org/10.2337/diabetes.47.4.668

  6. Khan, A

    1. Physiological insulinemia acutely modulates plasma leptin.
      M F Saad, A Khan, A Sharma, R Michael, M G Riad-Gabriel, R Boyadjian, S D Jinagouda, G M Steil and V Kamdar
      Diabetes 1998 Apr; 47 (4): 544-549. https://doi.org/10.2337/diabetes.47.4.544

  7. Kilpatrick, E D

    1. Differentiation between glucose-induced desensitization of insulin secretion and beta-cell exhaustion in the HIT-T15 cell line.
      E D Kilpatrick and R P Robertson
      Diabetes 1998 Apr; 47 (4): 606-611. https://doi.org/10.2337/diabetes.47.4.606

  8. Kim, K H

    1. Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein.
      H S Jun, Y Kang, H S Yoon, K H Kim, A L Notkins and J W Yoon
      Diabetes 1998 Apr; 47 (4): 576-582. https://doi.org/10.2337/diabetes.47.4.576

  9. Kishi, K

    1. Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.
      K Kishi, N Muromoto, Y Nakaya, I Miyata, A Hagi, H Hayashi and Y Ebina
      Diabetes 1998 Apr; 47 (4): 550-558. https://doi.org/10.2337/diabetes.47.4.550

  10. Kishikawa, H

    1. Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
      K Tsuruzoe, E Araki, N Furukawa, T Shirotani, K Matsumoto, K Kaneko, H Motoshima, K Yoshizato, A Shirakami, H Kishikawa, J Miyazaki and M Shichiri
      Diabetes 1998 Apr; 47 (4): 621-631. https://doi.org/10.2337/diabetes.47.4.621

  11. Kuijper, J L

    1. Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting.
      D G Baskin, R J Seeley, J L Kuijper, S Lok, D S Weigle, J C Erickson, R D Palmiter and M W Schwartz
      Diabetes 1998 Apr; 47 (4): 538-543. https://doi.org/10.2337/diabetes.47.4.538

  12. Kwon, G

    1. Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
      G Kwon, J A Corbett, S Hauser, J R Hill, J Turk and M L McDaniel
      Diabetes 1998 Apr; 47 (4): 583-591. https://doi.org/10.2337/diabetes.47.4.583

L

  1. Lan, M S

    1. The relationship between humoral and cellular immunity to IA-2 in IDDM.
      T M Ellis, D A Schatz, E W Ottendorfer, M S Lan, C Wasserfall, P J Salisbury, J X She, A L Notkins, N K Maclaren and M A Atkinson
      Diabetes 1998 Apr; 47 (4): 566-569. https://doi.org/10.2337/diabetes.47.4.566

  2. Larsen, P J

    1. Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment.
      M Tang-Christensen, N Vrang and P J Larsen
      Diabetes 1998 Apr; 47 (4): 530-537. https://doi.org/10.2337/diabetes.47.4.530

  3. Leonetti, D L

    1. Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.
      S E Kahn, C B Verchere, S Andrikopoulos, P J Asberry, D L Leonetti, P W Wahl, E J Boyko, R S Schwartz, L Newell-Morris and W Y Fujimoto
      Diabetes 1998 Apr; 47 (4): 640-645. https://doi.org/10.2337/diabetes.47.4.640

  4. Liang, L

    1. The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice.
      L Liang, E Beshay and G J Prud'homme
      Diabetes 1998 Apr; 47 (4): 570-575. https://doi.org/10.2337/diabetes.47.4.570

  5. Lien, P

    1. BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones.
      S C Souza, M T Yamamoto, M D Franciosa, P Lien and A S Greenberg
      Diabetes 1998 Apr; 47 (4): 691-695. https://doi.org/10.2337/diabetes.47.4.691

  6. Likes, C E

    1. Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African-American subjects.
      G Argyropoulos, A M Brown, R Peterson, C E Likes, D K Watson and W T Garvey
      Diabetes 1998 Apr; 47 (4): 685-687. https://doi.org/10.2337/diabetes.47.4.685

  7. Liu, L S

    1. Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor.
      L S Liu, M Spelleken, K Röhrig, H Hauner and J Eckel
      Diabetes 1998 Apr; 47 (4): 515-522. https://doi.org/10.2337/diabetes.47.4.515

  8. Lok, S

    1. Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting.
      D G Baskin, R J Seeley, J L Kuijper, S Lok, D S Weigle, J C Erickson, R D Palmiter and M W Schwartz
      Diabetes 1998 Apr; 47 (4): 538-543. https://doi.org/10.2337/diabetes.47.4.538

M

  1. Maclaren, N K

    1. The relationship between humoral and cellular immunity to IA-2 in IDDM.
      T M Ellis, D A Schatz, E W Ottendorfer, M S Lan, C Wasserfall, P J Salisbury, J X She, A L Notkins, N K Maclaren and M A Atkinson
      Diabetes 1998 Apr; 47 (4): 566-569. https://doi.org/10.2337/diabetes.47.4.566

  2. Mannan, N

    1. Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians.
      G A Hitman, N Mannan, M F McDermott, E Aganna, B W Ogunkolade, C N Hales and B J Boucher
      Diabetes 1998 Apr; 47 (4): 688-690. https://doi.org/10.2337/diabetes.47.4.688

  3. Marshall, B A

    1. Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling.
      L A Scrocchi, B A Marshall, S M Cook, P L Brubaker and D J Drucker
      Diabetes 1998 Apr; 47 (4): 632-639. https://doi.org/10.2337/diabetes.47.4.632

  4. Matsumoto, K

    1. Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
      K Tsuruzoe, E Araki, N Furukawa, T Shirotani, K Matsumoto, K Kaneko, H Motoshima, K Yoshizato, A Shirakami, H Kishikawa, J Miyazaki and M Shichiri
      Diabetes 1998 Apr; 47 (4): 621-631. https://doi.org/10.2337/diabetes.47.4.621

  5. Mazzocchi, C

    1. Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.
      C Ferri, G Desideri, R Baldoncini, C Bellini, C De Angelis, C Mazzocchi and A Santucci
      Diabetes 1998 Apr; 47 (4): 660-667. https://doi.org/10.2337/diabetes.47.4.660

  6. McDaniel, M L

    1. Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
      G Kwon, J A Corbett, S Hauser, J R Hill, J Turk and M L McDaniel
      Diabetes 1998 Apr; 47 (4): 583-591. https://doi.org/10.2337/diabetes.47.4.583

  7. McDermott, M F

    1. Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians.
      G A Hitman, N Mannan, M F McDermott, E Aganna, B W Ogunkolade, C N Hales and B J Boucher
      Diabetes 1998 Apr; 47 (4): 688-690. https://doi.org/10.2337/diabetes.47.4.688

  8. Menger, M D

    1. Vascularization of purified pancreatic islet-like cell aggregates (pseudoislets) after syngeneic transplantation.
      C Beger, V Cirulli, P Vajkoczy, P A Halban and M D Menger
      Diabetes 1998 Apr; 47 (4): 559-565. https://doi.org/10.2337/diabetes.47.4.559

  9. Michael, R

    1. Physiological insulinemia acutely modulates plasma leptin.
      M F Saad, A Khan, A Sharma, R Michael, M G Riad-Gabriel, R Boyadjian, S D Jinagouda, G M Steil and V Kamdar
      Diabetes 1998 Apr; 47 (4): 544-549. https://doi.org/10.2337/diabetes.47.4.544

  10. Miyata, I

    1. Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.
      K Kishi, N Muromoto, Y Nakaya, I Miyata, A Hagi, H Hayashi and Y Ebina
      Diabetes 1998 Apr; 47 (4): 550-558. https://doi.org/10.2337/diabetes.47.4.550

  11. Miyazaki, J

    1. Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
      K Tsuruzoe, E Araki, N Furukawa, T Shirotani, K Matsumoto, K Kaneko, H Motoshima, K Yoshizato, A Shirakami, H Kishikawa, J Miyazaki and M Shichiri
      Diabetes 1998 Apr; 47 (4): 621-631. https://doi.org/10.2337/diabetes.47.4.621

  12. Møller, A M

    1. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
      T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
      Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598

  13. Motoshima, H

    1. Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
      K Tsuruzoe, E Araki, N Furukawa, T Shirotani, K Matsumoto, K Kaneko, H Motoshima, K Yoshizato, A Shirakami, H Kishikawa, J Miyazaki and M Shichiri
      Diabetes 1998 Apr; 47 (4): 621-631. https://doi.org/10.2337/diabetes.47.4.621

  14. Muromoto, N

    1. Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.
      K Kishi, N Muromoto, Y Nakaya, I Miyata, A Hagi, H Hayashi and Y Ebina
      Diabetes 1998 Apr; 47 (4): 550-558. https://doi.org/10.2337/diabetes.47.4.550

N

  1. Nakaya, Y

    1. Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.
      K Kishi, N Muromoto, Y Nakaya, I Miyata, A Hagi, H Hayashi and Y Ebina
      Diabetes 1998 Apr; 47 (4): 550-558. https://doi.org/10.2337/diabetes.47.4.550

  2. Neal, D W

    1. Basal hepatic glucose production is regulated by the portal vein insulin concentration.
      D K Sindelar, C A Chu, P Venson, E P Donahue, D W Neal and A D Cherrington
      Diabetes 1998 Apr; 47 (4): 523-529. https://doi.org/10.2337/diabetes.47.4.523

  3. Newell-Morris, L

    1. Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.
      S E Kahn, C B Verchere, S Andrikopoulos, P J Asberry, D L Leonetti, P W Wahl, E J Boyko, R S Schwartz, L Newell-Morris and W Y Fujimoto
      Diabetes 1998 Apr; 47 (4): 640-645. https://doi.org/10.2337/diabetes.47.4.640

  4. Notkins, A L

    1. The relationship between humoral and cellular immunity to IA-2 in IDDM.
      T M Ellis, D A Schatz, E W Ottendorfer, M S Lan, C Wasserfall, P J Salisbury, J X She, A L Notkins, N K Maclaren and M A Atkinson
      Diabetes 1998 Apr; 47 (4): 566-569. https://doi.org/10.2337/diabetes.47.4.566
    2. Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein.
      H S Jun, Y Kang, H S Yoon, K H Kim, A L Notkins and J W Yoon
      Diabetes 1998 Apr; 47 (4): 576-582. https://doi.org/10.2337/diabetes.47.4.576

O

  1. Ogunkolade, B W

    1. Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians.
      G A Hitman, N Mannan, M F McDermott, E Aganna, B W Ogunkolade, C N Hales and B J Boucher
      Diabetes 1998 Apr; 47 (4): 688-690. https://doi.org/10.2337/diabetes.47.4.688

  2. Ottendorfer, E W

    1. The relationship between humoral and cellular immunity to IA-2 in IDDM.
      T M Ellis, D A Schatz, E W Ottendorfer, M S Lan, C Wasserfall, P J Salisbury, J X She, A L Notkins, N K Maclaren and M A Atkinson
      Diabetes 1998 Apr; 47 (4): 566-569. https://doi.org/10.2337/diabetes.47.4.566

P

  1. Palmiter, R D

    1. Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting.
      D G Baskin, R J Seeley, J L Kuijper, S Lok, D S Weigle, J C Erickson, R D Palmiter and M W Schwartz
      Diabetes 1998 Apr; 47 (4): 538-543. https://doi.org/10.2337/diabetes.47.4.538

  2. Pedersen, O

    1. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
      T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
      Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598

  3. Permutt, M A

    1. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
      T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
      Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598

  4. Peterson, R

    1. Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African-American subjects.
      G Argyropoulos, A M Brown, R Peterson, C E Likes, D K Watson and W T Garvey
      Diabetes 1998 Apr; 47 (4): 685-687. https://doi.org/10.2337/diabetes.47.4.685

  5. Pipeleers, D

    1. Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
      D Flamez, A Van Breusegem, L A Scrocchi, E Quartier, D Pipeleers, D J Drucker and F Schuit
      Diabetes 1998 Apr; 47 (4): 646-652. https://doi.org/10.2337/diabetes.47.4.646

  6. Prud'homme, G J

    1. The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice.
      L Liang, E Beshay and G J Prud'homme
      Diabetes 1998 Apr; 47 (4): 570-575. https://doi.org/10.2337/diabetes.47.4.570

Q

  1. Quartier, E

    1. Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
      D Flamez, A Van Breusegem, L A Scrocchi, E Quartier, D Pipeleers, D J Drucker and F Schuit
      Diabetes 1998 Apr; 47 (4): 646-652. https://doi.org/10.2337/diabetes.47.4.646

R

  1. Riad-Gabriel, M G

    1. Physiological insulinemia acutely modulates plasma leptin.
      M F Saad, A Khan, A Sharma, R Michael, M G Riad-Gabriel, R Boyadjian, S D Jinagouda, G M Steil and V Kamdar
      Diabetes 1998 Apr; 47 (4): 544-549. https://doi.org/10.2337/diabetes.47.4.544

  2. Rimvall, K

    1. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
      G M Castillo, J A Cummings, W Yang, M E Judge, M J Sheardown, K Rimvall, J B Hansen and A D Snow
      Diabetes 1998 Apr; 47 (4): 612-620. https://doi.org/10.2337/diabetes.47.4.612

  3. Robertson, R P

    1. Differentiation between glucose-induced desensitization of insulin secretion and beta-cell exhaustion in the HIT-T15 cell line.
      E D Kilpatrick and R P Robertson
      Diabetes 1998 Apr; 47 (4): 606-611. https://doi.org/10.2337/diabetes.47.4.606

  4. Röhrig, K

    1. Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor.
      L S Liu, M Spelleken, K Röhrig, H Hauner and J Eckel
      Diabetes 1998 Apr; 47 (4): 515-522. https://doi.org/10.2337/diabetes.47.4.515

S

  1. Saad, M F

    1. Physiological insulinemia acutely modulates plasma leptin.
      M F Saad, A Khan, A Sharma, R Michael, M G Riad-Gabriel, R Boyadjian, S D Jinagouda, G M Steil and V Kamdar
      Diabetes 1998 Apr; 47 (4): 544-549. https://doi.org/10.2337/diabetes.47.4.544

  2. Salisbury, P J

    1. The relationship between humoral and cellular immunity to IA-2 in IDDM.
      T M Ellis, D A Schatz, E W Ottendorfer, M S Lan, C Wasserfall, P J Salisbury, J X She, A L Notkins, N K Maclaren and M A Atkinson
      Diabetes 1998 Apr; 47 (4): 566-569. https://doi.org/10.2337/diabetes.47.4.566

  3. Santucci, A

    1. Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.
      C Ferri, G Desideri, R Baldoncini, C Bellini, C De Angelis, C Mazzocchi and A Santucci
      Diabetes 1998 Apr; 47 (4): 660-667. https://doi.org/10.2337/diabetes.47.4.660

  4. Schatz, D A

    1. The relationship between humoral and cellular immunity to IA-2 in IDDM.
      T M Ellis, D A Schatz, E W Ottendorfer, M S Lan, C Wasserfall, P J Salisbury, J X She, A L Notkins, N K Maclaren and M A Atkinson
      Diabetes 1998 Apr; 47 (4): 566-569. https://doi.org/10.2337/diabetes.47.4.566

  5. Schenker, M

    1. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
      J Dittler, D Seidel, M Schenker and A G Ziegler
      Diabetes 1998 Apr; 47 (4): 592-597. https://doi.org/10.2337/diabetes.47.4.592

  6. Schuit, F

    1. Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
      D Flamez, A Van Breusegem, L A Scrocchi, E Quartier, D Pipeleers, D J Drucker and F Schuit
      Diabetes 1998 Apr; 47 (4): 646-652. https://doi.org/10.2337/diabetes.47.4.646

  7. Schwartz, M W

    1. Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting.
      D G Baskin, R J Seeley, J L Kuijper, S Lok, D S Weigle, J C Erickson, R D Palmiter and M W Schwartz
      Diabetes 1998 Apr; 47 (4): 538-543. https://doi.org/10.2337/diabetes.47.4.538

  8. Schwartz, R S

    1. Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.
      S E Kahn, C B Verchere, S Andrikopoulos, P J Asberry, D L Leonetti, P W Wahl, E J Boyko, R S Schwartz, L Newell-Morris and W Y Fujimoto
      Diabetes 1998 Apr; 47 (4): 640-645. https://doi.org/10.2337/diabetes.47.4.640

  9. Scrocchi, L A

    1. Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling.
      L A Scrocchi, B A Marshall, S M Cook, P L Brubaker and D J Drucker
      Diabetes 1998 Apr; 47 (4): 632-639. https://doi.org/10.2337/diabetes.47.4.632
    2. Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
      D Flamez, A Van Breusegem, L A Scrocchi, E Quartier, D Pipeleers, D J Drucker and F Schuit
      Diabetes 1998 Apr; 47 (4): 646-652. https://doi.org/10.2337/diabetes.47.4.646

  10. Seeley, R J

    1. Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting.
      D G Baskin, R J Seeley, J L Kuijper, S Lok, D S Weigle, J C Erickson, R D Palmiter and M W Schwartz
      Diabetes 1998 Apr; 47 (4): 538-543. https://doi.org/10.2337/diabetes.47.4.538

  11. Seidel, D

    1. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
      J Dittler, D Seidel, M Schenker and A G Ziegler
      Diabetes 1998 Apr; 47 (4): 592-597. https://doi.org/10.2337/diabetes.47.4.592

  12. Sharma, A

    1. Physiological insulinemia acutely modulates plasma leptin.
      M F Saad, A Khan, A Sharma, R Michael, M G Riad-Gabriel, R Boyadjian, S D Jinagouda, G M Steil and V Kamdar
      Diabetes 1998 Apr; 47 (4): 544-549. https://doi.org/10.2337/diabetes.47.4.544

  13. She, J X

    1. The relationship between humoral and cellular immunity to IA-2 in IDDM.
      T M Ellis, D A Schatz, E W Ottendorfer, M S Lan, C Wasserfall, P J Salisbury, J X She, A L Notkins, N K Maclaren and M A Atkinson
      Diabetes 1998 Apr; 47 (4): 566-569. https://doi.org/10.2337/diabetes.47.4.566

  14. Sheardown, M J

    1. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
      G M Castillo, J A Cummings, W Yang, M E Judge, M J Sheardown, K Rimvall, J B Hansen and A D Snow
      Diabetes 1998 Apr; 47 (4): 612-620. https://doi.org/10.2337/diabetes.47.4.612

  15. Shichiri, M

    1. Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
      K Tsuruzoe, E Araki, N Furukawa, T Shirotani, K Matsumoto, K Kaneko, H Motoshima, K Yoshizato, A Shirakami, H Kishikawa, J Miyazaki and M Shichiri
      Diabetes 1998 Apr; 47 (4): 621-631. https://doi.org/10.2337/diabetes.47.4.621

  16. Shirakami, A

    1. Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
      K Tsuruzoe, E Araki, N Furukawa, T Shirotani, K Matsumoto, K Kaneko, H Motoshima, K Yoshizato, A Shirakami, H Kishikawa, J Miyazaki and M Shichiri
      Diabetes 1998 Apr; 47 (4): 621-631. https://doi.org/10.2337/diabetes.47.4.621

  17. Shirotani, T

    1. Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
      K Tsuruzoe, E Araki, N Furukawa, T Shirotani, K Matsumoto, K Kaneko, H Motoshima, K Yoshizato, A Shirakami, H Kishikawa, J Miyazaki and M Shichiri
      Diabetes 1998 Apr; 47 (4): 621-631. https://doi.org/10.2337/diabetes.47.4.621

  18. Sindelar, D K

    1. Basal hepatic glucose production is regulated by the portal vein insulin concentration.
      D K Sindelar, C A Chu, P Venson, E P Donahue, D W Neal and A D Cherrington
      Diabetes 1998 Apr; 47 (4): 523-529. https://doi.org/10.2337/diabetes.47.4.523

  19. Snow, A D

    1. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
      G M Castillo, J A Cummings, W Yang, M E Judge, M J Sheardown, K Rimvall, J B Hansen and A D Snow
      Diabetes 1998 Apr; 47 (4): 612-620. https://doi.org/10.2337/diabetes.47.4.612

  20. Souza, S C

    1. BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones.
      S C Souza, M T Yamamoto, M D Franciosa, P Lien and A S Greenberg
      Diabetes 1998 Apr; 47 (4): 691-695. https://doi.org/10.2337/diabetes.47.4.691

  21. Spelleken, M

    1. Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor.
      L S Liu, M Spelleken, K Röhrig, H Hauner and J Eckel
      Diabetes 1998 Apr; 47 (4): 515-522. https://doi.org/10.2337/diabetes.47.4.515

  22. Spiegelman, B M

    1. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
      B M Spiegelman
      Diabetes 1998 Apr; 47 (4): 507-514. https://doi.org/10.2337/diabetes.47.4.507

  23. Steil, G M

    1. Physiological insulinemia acutely modulates plasma leptin.
      M F Saad, A Khan, A Sharma, R Michael, M G Riad-Gabriel, R Boyadjian, S D Jinagouda, G M Steil and V Kamdar
      Diabetes 1998 Apr; 47 (4): 544-549. https://doi.org/10.2337/diabetes.47.4.544

T

  1. Tang-Christensen, M

    1. Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment.
      M Tang-Christensen, N Vrang and P J Larsen
      Diabetes 1998 Apr; 47 (4): 530-537. https://doi.org/10.2337/diabetes.47.4.530

  2. Tsuruzoe, K

    1. Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
      K Tsuruzoe, E Araki, N Furukawa, T Shirotani, K Matsumoto, K Kaneko, H Motoshima, K Yoshizato, A Shirakami, H Kishikawa, J Miyazaki and M Shichiri
      Diabetes 1998 Apr; 47 (4): 621-631. https://doi.org/10.2337/diabetes.47.4.621

  3. Turk, J

    1. Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
      G Kwon, J A Corbett, S Hauser, J R Hill, J Turk and M L McDaniel
      Diabetes 1998 Apr; 47 (4): 583-591. https://doi.org/10.2337/diabetes.47.4.583

U

  1. Urhammer, S A

    1. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
      T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
      Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598

V

  1. Vajkoczy, P

    1. Vascularization of purified pancreatic islet-like cell aggregates (pseudoislets) after syngeneic transplantation.
      C Beger, V Cirulli, P Vajkoczy, P A Halban and M D Menger
      Diabetes 1998 Apr; 47 (4): 559-565. https://doi.org/10.2337/diabetes.47.4.559

  2. Van Breusegem, A

    1. Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
      D Flamez, A Van Breusegem, L A Scrocchi, E Quartier, D Pipeleers, D J Drucker and F Schuit
      Diabetes 1998 Apr; 47 (4): 646-652. https://doi.org/10.2337/diabetes.47.4.646

  3. Venson, P

    1. Basal hepatic glucose production is regulated by the portal vein insulin concentration.
      D K Sindelar, C A Chu, P Venson, E P Donahue, D W Neal and A D Cherrington
      Diabetes 1998 Apr; 47 (4): 523-529. https://doi.org/10.2337/diabetes.47.4.523

  4. Verchere, C B

    1. Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.
      S E Kahn, C B Verchere, S Andrikopoulos, P J Asberry, D L Leonetti, P W Wahl, E J Boyko, R S Schwartz, L Newell-Morris and W Y Fujimoto
      Diabetes 1998 Apr; 47 (4): 640-645. https://doi.org/10.2337/diabetes.47.4.640

  5. Vrang, N

    1. Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment.
      M Tang-Christensen, N Vrang and P J Larsen
      Diabetes 1998 Apr; 47 (4): 530-537. https://doi.org/10.2337/diabetes.47.4.530

W

  1. Wahl, P W

    1. Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.
      S E Kahn, C B Verchere, S Andrikopoulos, P J Asberry, D L Leonetti, P W Wahl, E J Boyko, R S Schwartz, L Newell-Morris and W Y Fujimoto
      Diabetes 1998 Apr; 47 (4): 640-645. https://doi.org/10.2337/diabetes.47.4.640

  2. Wasserfall, C

    1. The relationship between humoral and cellular immunity to IA-2 in IDDM.
      T M Ellis, D A Schatz, E W Ottendorfer, M S Lan, C Wasserfall, P J Salisbury, J X She, A L Notkins, N K Maclaren and M A Atkinson
      Diabetes 1998 Apr; 47 (4): 566-569. https://doi.org/10.2337/diabetes.47.4.566

  3. Watson, D K

    1. Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African-American subjects.
      G Argyropoulos, A M Brown, R Peterson, C E Likes, D K Watson and W T Garvey
      Diabetes 1998 Apr; 47 (4): 685-687. https://doi.org/10.2337/diabetes.47.4.685

  4. Weigle, D S

    1. Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting.
      D G Baskin, R J Seeley, J L Kuijper, S Lok, D S Weigle, J C Erickson, R D Palmiter and M W Schwartz
      Diabetes 1998 Apr; 47 (4): 538-543. https://doi.org/10.2337/diabetes.47.4.538

  5. Wentzel, P

    1. Antioxidants diminish developmental damage induced by high glucose and cyclooxygenase inhibitors in rat embryos in vitro.
      P Wentzel and U J Eriksson
      Diabetes 1998 Apr; 47 (4): 677-684. https://doi.org/10.2337/diabetes.47.4.677

  6. Whiteside, C

    1. Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells.
      T Babazono, J Kapor-Drezgic, J A Dlugosz and C Whiteside
      Diabetes 1998 Apr; 47 (4): 668-676. https://doi.org/10.2337/diabetes.47.4.668

Y

  1. Yamamoto, M T

    1. BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones.
      S C Souza, M T Yamamoto, M D Franciosa, P Lien and A S Greenberg
      Diabetes 1998 Apr; 47 (4): 691-695. https://doi.org/10.2337/diabetes.47.4.691

  2. Yang, W

    1. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
      G M Castillo, J A Cummings, W Yang, M E Judge, M J Sheardown, K Rimvall, J B Hansen and A D Snow
      Diabetes 1998 Apr; 47 (4): 612-620. https://doi.org/10.2337/diabetes.47.4.612

  3. Yoon, H S

    1. Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein.
      H S Jun, Y Kang, H S Yoon, K H Kim, A L Notkins and J W Yoon
      Diabetes 1998 Apr; 47 (4): 576-582. https://doi.org/10.2337/diabetes.47.4.576

  4. Yoon, J W

    1. Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein.
      H S Jun, Y Kang, H S Yoon, K H Kim, A L Notkins and J W Yoon
      Diabetes 1998 Apr; 47 (4): 576-582. https://doi.org/10.2337/diabetes.47.4.576

  5. Yoshizato, K

    1. Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
      K Tsuruzoe, E Araki, N Furukawa, T Shirotani, K Matsumoto, K Kaneko, H Motoshima, K Yoshizato, A Shirakami, H Kishikawa, J Miyazaki and M Shichiri
      Diabetes 1998 Apr; 47 (4): 621-631. https://doi.org/10.2337/diabetes.47.4.621

Z

  1. Ziegler, A G

    1. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
      J Dittler, D Seidel, M Schenker and A G Ziegler
      Diabetes 1998 Apr; 47 (4): 592-597. https://doi.org/10.2337/diabetes.47.4.592
Back to top

In this Issue

April 1998, 47(4)
Sign up to receive current issue alerts
View Selected Citations (0)